Advances in biology and medicine might expand the range of our scientific capabilities, but shed no light on what we should do, how those capabilities should be used.
That’s where the field of bioethics comes in.
The new Stavros Niarchos Foundation Bioethics Academy (SNFBA) will expand awareness of bioethics in Greece. Conducted through a partnership between the Berman Institute of Bioethics at Johns Hopkins University and the Bioethics Chair at the Swiss Federal Institute of Technology (ETH) and exclusively supported by the Stavros Niarchos Foundation (SNF), the Academy will include components taking place in Athens, Zurich, and Baltimore.
Each June, an intensive summer bioethics course will be offered in Athens. This year, the course will take place from June 20 to 22 at the Stavros Niarchos Foundation Cultural Center (SNFCC), created through SNF’s largest grant to date. The course will be co-directed by Professors Jeffrey Kahn, the Andreas C. Dracopoulos Director of the Berman Institute, and Effy Vayena, Head of the Health Ethics and Policy Lab at ETH. Lectures and small group discussions will focus on Greek cases that raise ethical questions related to clinical medicine and biomedical research.
Applications for the summer course are now open, and will remain open until June 7, 2019 unless the 40 available slots are filled before then. Biomedical researchers, clinical researchers, biobank researchers, and those involved in ethics and deontology committees are encouraged to apply.
SNF has looked to open conversations on bioethics in a range of venues. Professor Kahn participated last week in a panel discussion on “Gene Editing and the Future of Human Health” at New York Stem Cell Foundation, supported by SNF. This spring, the Stavros Niarchos Foundation Agora Institute at Johns Hopkins University and Theater of War Productions, another SNF grantee, collaborated in exploring a new angle of approach in discussion on illness, palliative care, and death. Readings from ancient Greek plays served as the basis for a conversation that included medical professionals from Johns Hopkins University and professors from the Berman Institute.